Metoclopramide, a drug with oxidant activity, has infrequently been re
ported to cause methemoglobinemia in infants. We present a unique case
in which a patient on chronic metoclopramide therapy developed sulfhe
moglobinemia that resolved with subsequent discontinuation of the drug
. Mechanisms that may be important in the formation of sulfhemoglobin
also are discussed.